Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Tolfenamic acid

EU orphan designation number: EU/3/16/1613   
Active ingredient: Tolfenamic acid
Indication: Treatment of progressive supranuclear palsy
Sponsor: RV Developpement
5 Résidence des Prés, 57510 Puttelange-aux-Lacs, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/02/2016 Orphan designation EMA/OD/193/15 (2016)1106 of 17/02/2016